The neurohormonal peptide somatostatin acts as an important regulator of a variety of functions in the gastrointestinal tract. In the previous 12 years of its funding, this project has focused on three aspects of gastrointestinal somatostatin: 1) mechanisms of somatostatin biosynthesis and post-translational processing, 2) mechanisms of somatostatin secretion from gastric D-cells, and 3) mechanisms of somatostatin's inhibitory actions on gastric acid secretion. The current application proposes to extend ongoing studies in these three areas. To explore the mechanisms of somatostatin processing, somatostatin cDNA will be expressed in heterologous endocrine cells and the expressed products will be analyzed. The substrate specificity of the processing enzymes will be studies by mutating the key processing sites and examining the expression products. The cDNAs encoding PC2 and PC3, two putative mammalian dibasic cleavage enzymes, will be co-expressed in cells that do not process somatostatin efficiently to determine whether they can function as somatostatin """"""""convertases."""""""" An effort will be made to isolate cDNA clones encoding somatostatin processing enzymes by screening canine D-cell and RIN cell cDNA libraries with probes derived by polymerase chain reaction using primers based on homology to PC2 and PC3. In other studies, the mechanism by which carbachol, cholecystokinin (CCK), and gastrin all have different actions in D-cells despite the observation that they all induce D-cell membrane inositol phospholipid (PI) turnover will be explored. For these studies, we will examine the effects of these agonists alone and in combination with each other and with reagents such as 12-0-tetradecanoyl- phorbol-13-acetate and thapsigargin not only on PI turnover but also on [Ca++]i in single D-cells by microspectrofluorometry and on pertussis toxin and cholera toxin sensitive G-proteins by studies of ADP-ribosylation. To explore the mechanisms of somatostatin's inhibitory actions on acid secretion we will pursue our previous observation that somatostatin inhibits parietal cell carbonic anhydrase II (CA II) gene expression in a fashion that is paralleled by inhibition of the expression of the immediate early gene c-fos. We will examine the cis-regulatory elements of the CA II that are sensitive to somatostatin via expressing in somatostatin receptor- containing GH3 cells a construct consisting of the CA II promoter linked to a chloramphenicol acetyl transferase (CAT) reporter gene. To confirm the linkage between the effects of somatostatin on expression of CA II and c- fos, we will attempt to overcome the inhibitory effect of somatostatin on CA II-CAT expression by overexpressing c-fos in the same cells. Furthermore, we will examine the effect of mutating the c-fos sensitive AP- 1 binding sites of the CA II promoter on the inhibitory actions of somatostatin. An effort will be made to identify the somatostatin sensitive elements of the c-fos gene using portions of the c-fos promoter/enhancer segment in constructs with the CAT reporter gene. Through these studies we hope to gain insight into the cellular and molecular mechanisms governing the synthesis, secretion, and actions of somatostatin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK033500-12
Application #
2139083
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1983-06-01
Project End
1996-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
12
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Gantz, I; Konda, Y; Yang, Y K et al. (1996) Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenet Cell Genet 74:286-90
Kaise, M; Muraoka, A; Yamada, J et al. (1995) Epidermal growth factor induces H+,K+-ATPase alpha-subunit gene expression through an element homologous to the 3' half-site of the c-fos serum response element. J Biol Chem 270:18637-42
Song, I; Mortell, M P; Gantz, I et al. (1993) Molecular cloning and structural analysis of canine gastric H+,K(+)-ATPase. Biochem Biophys Res Commun 196:1240-7
Yamada, T (1990) Isolation and primary culture of endocrine cells from canine gastric mucosa. Methods Enzymol 192:176-87
Chiba, T; Park, J; Yamada, T (1988) Biosynthesis of somatostatin in canine fundic D cells. J Clin Invest 81:282-7
Blackstone, C D; Seino, S; Takeuchi, T et al. (1988) Novel organization and processing of the guinea pig pancreatic polypeptide precursor. J Biol Chem 263:2911-6